【结 构 式】 |
【分子编号】66864 【品名】dimethyl 2-(1-(3-nitrophenyl)allyl)malonate 【CA登记号】 |
【 分 子 式 】C14H15NO6 【 分 子 量 】293.27624 【元素组成】C 57.34% H 5.16% N 4.78% O 32.73% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(III)
【1】 Trost BM, Andersen NG. 2002. Utilization of molybdenum-and palladium-catalyzed dynamic kinetic asymmetric transformations for the preparation of tertiary and quatemary stereogenic centers; a concise synthesis of tipranavir. J Am Chem Soc, 124 (48): 14320~14321 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IV) | 66865 | methyl 3-(3-nitrophenyl)pent-4-enoate | C12H13NO4 | 详情 | 详情 | |
(V) | 16524 | bromo(vinyl)magnesium | 1826-67-1 | C2H3BrMg | 详情 | 详情 |
(VII) | 66867 | 1-propyl-1-vinylcyclopropane | C8H14 | 详情 | 详情 | |
(IX) | 66869 | (E)-2-((4-methoxybenzyl)oxy)-2-styrylpentan-1-ol | C21H26O3 | 详情 | 详情 | |
(XII) | 66872 | (5S)-methyl 5-((4-methoxybenzyl)oxy)-2-((R)-1-(3-nitrophenyl)allyl)-3-oxo-5-phenethyloctanoate | C34H39NO7 | 详情 | 详情 | |
(XIII) | 66873 | (5S)-methyl 5-hydroxy-2-((R)-1-(3-nitrophenyl)allyl)-3-oxo-5-phenethyloctanoate | C26H31NO6 | 详情 | 详情 | |
(XIV) | 66874 | (S)-4-hydroxy-3-((R)-1-(3-nitrophenyl)allyl)-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H27NO5 | 详情 | 详情 | |
(XV) | 21168 | (6R)-4-hydroxy-3-[(1R)-1-(3-nitrophenyl)propyl]-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one | C25H29NO5 | 详情 | 详情 | |
(I) | 66862 | 1-(3-nitrophenyl)prop-2-en-1-ol | C9H9NO3 | 详情 | 详情 | |
(II) | 66863 | tert-butyl (1-(3-nitrophenyl)allyl) carbonate | C14H17NO5 | 详情 | 详情 | |
(III) | 66864 | dimethyl 2-(1-(3-nitrophenyl)allyl)malonate | C14H15NO6 | 详情 | 详情 | |
(VI) | 66866 | 1-chloropentan-2-one | C5H9ClO | 详情 | 详情 | |
(VIII) | 66868 | 2-((4-methoxybenzyl)oxy)-2-vinylpentan-1-ol | C15H22O3 | 详情 | 详情 | |
(X) | 66870 | 2-((4-methoxybenzyl)oxy)-2-phenethylpentan-1-ol | C21H28O3 | 详情 | 详情 | |
(XI) | 66871 | 1-methoxy-4-(((3-phenethylhex-1-en-3-yl)oxy)methyl)benzene | C22H28O2 | 详情 | 详情 | |
(XVI) | 66879 | 2-((4-methoxybenzyl)oxy)-2-phenethylpentanal | C21H26O3 | 详情 | 详情 |
Extended Information